Potential interactions among myricetin and dietary flavonols through the inhibition of human UDP-glucuronosyltransferase in vitro
- 19 January 2022
- journal article
- research article
- Published by Elsevier BV in Toxicology Letters
- Vol. 358, 40-47
- https://doi.org/10.1016/j.toxlet.2022.01.007
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Drug-Drug Interactions Potential of Icariin and Its Intestinal Metabolites via Inhibition of Intestinal UDP-GlucuronosyltransferasesEvidence-Based Complementary and Alternative Medicine, 2012
- Myricetin attenuates lipopolysaccharide‐stimulated activation of mouse bone marrow‐derived dendritic cells through suppression of IKK/NF‐κB and MAPK signalling pathwaysJournal of the Science of Food and Agriculture, 2012
- Evaluation of metabolism-mediated herb-drug interactionsArchives of Pharmacal Research, 2011
- Dietary Flavonol and Flavone Intakes and Their Major Food Sources in Chinese AdultsNutrition and Cancer, 2010
- The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping andin vitro–in vivoextrapolation of drug clearance and drug-drug interaction potentialDrug Metabolism Reviews, 2009
- Mechanism-Based Inactivation of Human Cytochrome P450 Enzymes and the Prediction of Drug-Drug InteractionsDrug Metabolism and Disposition, 2006
- The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbitsJournal of Pharmacy and Pharmacology, 2004
- Inhibition of human cytochromes P450 by components of Ginkgo bilobaJournal of Pharmacy and Pharmacology, 2004
- HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECIDDrug Metabolism and Disposition, 2004
- DIETARY FLAVONOIDS: Bioavailability, Metabolic Effects, and SafetyAnnual Review of Nutrition, 2002